Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00917514

NCT00917514
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You can be either male or female
  • You must be 18 years old or older
  • You must be willing and able to sign a consent form agreeing to take part in the study
  • You must have been diagnosed with Crohn's disease or Ulcerative Colitis
  • You must have been taking a medication called Azathioprine for at least 6 months before the study begins

Who may not be able to join:

  • You may not be able to join if the trial doctor feels, for any reason, that you would not be able to properly use the device being tested in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Medicpen AB
Registry
clinicaltrials_gov
Start date
1 June 2009
Est. completion
1 February 2010

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

User friendliness of Dosing Tool MedicPen

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov